Danjuma Adda WHS Programme committee chair
Danjuma Adda WHS Programme committee chair

Welcome message

We look forward to welcoming you to the fourth WHS in Lisbon, Portugal. WHS is an innovative, large-scale, global meeting which pioneers changes within the fight against hepatitis by offering the opportunity to forge relationships between stakeholders for the development and implementation of elimination plans and strengthening of the community voice in the viral hepatitis response. 

Building on the legacies of previous summits, WHS 2024 comes at a crucial time, on the eve of the deadline for the Global Health Sector Strategy 2025 targets and at a time when there is both more opportunity for critical cross-sectoral partnerships and new challenges navigating post-Covid health systems. 

WHS strives to be a truly equitable conference with representation from across the world, and especially from those communities and countries who are disproportionately impacted. Reflecting this we are delighted that WHS 2024 will be a hybrid conference with those unable to join in-person able to access the content and networking online.

WHS 2024 is shaped by our programme committee and local advisory committee and with them we look forward to developing and delivering a vibrant and engaging summit.

Nos vemos em Lisboa! 

Danjuma Adda
WHS Programme Committee Co-Chair

Integrate Accelerate Eliminate


Our theme for 2024 is a call to action to: Integrate, Accelerate and Eliminate!

Integrate – hepatitis throughout health systems including programmes for cancer, maternal and child health, HIV, TB, harm reduction, non-communicable diseases, universal health coverage and primary health care.

Accelerate – action through community-led services, expanding testing and access to treatment, increasing advocacy, empowering people living with hepatitis, generating political commitment and developing new approaches to financing, generating and using data to target action and promote patient-centred care.

Eliminate – hepatitis by 2030 through forging new partnerships, generating unique synergies, and identifying opportunities for future collaboration.


The WHS 2024 objectives are to:
  1. Foster collaboration across a wide group of stakeholders to achieve elimination by increasing innovation, collaboration and joint-working.
  2. Promote the public health approach to hepatitis elimination which places people living with hepatitis and the affected communities at the centre of the response.
  3. Accelerate the sharing of best practice for the prevention, diagnosis and treatment of viral hepatitis.
  4. Empower governments to accelerate their efforts to reach the 2030 targets of eliminating viral hepatitis by building the knowledge and awareness of delegates.
  5. Provide a platform for the communities disproportionally affected by viral hepatitis, such as people living in endemic regions, people who inject drugs and indigenous peoples, to connect with decision makers and the wider sector.

Hepatitis and PWID/harm reduction 


11:35 – 11:40  

Chair: WHO – Intro and set the scene.  


11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 


11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 


12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.


12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 


12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 


12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  


12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.